Correction
Errataetall: |
ErratumFor: Expert Opin Emerg Drugs. 2024 Mar 28;:1-11. - PMID 38549232 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Expert opinion on emerging drugs - (2024) vom: 18. Apr., Seite 1 |
Sprache: |
Englisch |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 18.04.2024 published: Print-Electronic ErratumFor: Expert Opin Emerg Drugs. 2024 Mar 28;:1-11. - PMID 38549232 Citation Status Publisher |
---|
doi: |
10.1080/14728214.2024.2342646 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM371235219 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM371235219 | ||
003 | DE-627 | ||
005 | 20240418234045.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240418s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/14728214.2024.2342646 |2 doi | |
028 | 5 | 2 | |a pubmed24n1379.xml |
035 | |a (DE-627)NLM371235219 | ||
035 | |a (NLM)38634431 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
245 | 1 | 0 | |a Correction |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 18.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a ErratumFor: Expert Opin Emerg Drugs. 2024 Mar 28;:1-11. - PMID 38549232 | ||
500 | |a Citation Status Publisher | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Published Erratum | |
773 | 0 | 8 | |i Enthalten in |t Expert opinion on emerging drugs |d 2001 |g (2024) vom: 18. Apr., Seite 1 |w (DE-627)NLM143290835 |x 1744-7623 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:18 |g month:04 |g pages:1 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/14728214.2024.2342646 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 18 |c 04 |h 1 |